Company Overview - Tongling Jeya Biotechnology Co., Ltd. was established in 1999, specializing in the research, production, and sales of wet wipes, with over 20 years of industry experience [3]. - The company was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on December 3, 2021, and is currently advancing its fundraising projects [3]. Financial Performance - For the first three quarters of 2025, the company reported a revenue of CNY 565 million and a net profit of CNY 6.79 million [3]. - The primary reason for the revenue growth in 2025 is attributed to an increase in orders from foreign clients [3]. Business Strategy and Operations - The company is accelerating its global business layout, with expectations that foreign sales will account for over 50% of total business this year [3]. - The current capacity utilization rate is over 80%, and new capacity can be added within three to six months [3]. Future Plans - The U.S. factory is currently under construction, with plans to introduce automated production lines and optimize management processes to control costs, aiming for production in 2026 [3]. - Key future growth drivers include deepening cooperation with existing international brand clients and the new market opportunities presented by the U.S. factory [4]. Risk Factors - Investment risks associated with the U.S. factory include potential delays in production, customer approval processes, and cultural differences affecting production efficiency [3]. Competitive Advantages - The company has developed significant core competitive advantages in technology research and development, production processes, quality control, customer resources, and product variety through years of focused development in the wet wipes market [4].